AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Isryl-M1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Systopic Laboratories Pvt Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Isryl-M1 Tablet SR

DiabetaComb SR tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. DiabetaComb SR should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on blood sugar monitoring. Continuous use is crucial, even with seemingly controlled blood sugar; abrupt cessation can elevate glucose levels, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication is only one component of a comprehensive treatment plan, encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are pivotal in diabetes management. Hypoglycemia (low blood sugar) is a frequent side effect, manifested by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks or juice) are essential for prevention. Alcohol consumption should be minimized due to its hypoglycemic potential. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart conditions should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Isryl-M1 Tablet SR

Managing type 2 diabetes

Major Benefits of Isryl-M1 Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Isryl-M1 Tablet SR whole; avoid chewing, crushing, or breaking it. Administer this medication with food.

Common Side effects of Isryl-M1 Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Isryl-M1 Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Isryl-M1 Tablet SR with a meal.

How Isryl-M1 Tablet SR works:

Isryl-M1 SR tablets combine glimepiride, a sulfonylurea, and metformin, a biguanide, to manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin's action is threefold: it decreases hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Isryl-M1 Tablet SR and alcohol is inadvisable due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Isryl-M1 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingUNSAFE

Extended-release Isryl-M1 tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Isryl-M1 SR tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Isryl-M1 SR tablet use. Physician consultation is necessary. Routine monitoring of kidney function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Isryl-M1 Tablet SR cautiously, potentially requiring dosage modification. Consult a physician. A reduced initial dose is typically prescribed for individuals with mild to moderate hepatic dysfunction; however, Isryl-M1 Tablet SR is contraindicated in those with severe liver disease.

What if you forget to take Isryl-M1 Tablet SR :

Should you forget to take your Isryl-M1 Tablet SR, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Isryl-M1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Isryl-M1 Tablet SR

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medicine and keep it out of reach of children, pets, and others.
Isryl-M1 Tablet SR can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but dangerous side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Isryl-M1 Tablet SR and seek immediate medical attention.
Isryl-M1 SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Isryl-M1 SR tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged Isryl-M1 Tablet SR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Isryl-M1 SR tablets can cause low blood sugar (hypoglycemia), characterized by symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases if meals are skipped or delayed, alcohol is consumed, excessive exercise is undertaken, or other diabetes medications are used concurrently. Therefore, regular blood sugar monitoring is crucial. Always carry a readily available fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Isryl-M1 Tablet SR and alcohol is unsafe. Alcohol can exacerbate Isryl-M1's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Isryl-M1 Tablet SR
34
MRP 42
19% off